{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T15:06:17Z","timestamp":1698073577500},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1984,1,1]],"date-time":"1984-01-01T00:00:00Z","timestamp":441763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1984]]},"DOI":"10.1007\/bf00542163","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T04:07:21Z","timestamp":1100837241000},"page":"297-302","source":"Crossref","is-referenced-by-count":7,"title":["Antipyrine clearance in patients with Gilbert's syndrome"],"prefix":"10.1007","volume":"27","author":[{"given":"T.","family":"Ishizaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2125.1977.tb00710.x","volume":"4","author":"IH Stevenson","year":"1977","unstructured":"Stevenson IH (1977) Factors influencing antipyrine elimination. Br J Clin Pharmacol 4: 261?265","journal-title":"Br J Clin Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cpt1979263275","volume":"26","author":"EF Vesell","year":"1979","unstructured":"Vesell EF (1979) The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clin Pharmacol Ther 26: 275?286","journal-title":"Clin Pharmacol Ther"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/cpt1975184425","volume":"18","author":"RE Vestal","year":"1975","unstructured":"Vestal RE, Norris AH, Tobin JD, Cohen BH, Shock NW, Andres R (1975) Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking. Clin Pharmacol Ther 18: 425?432","journal-title":"Clin Pharmacol Ther"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cpt1977225part2799","volume":"22","author":"HS Fraser","year":"1977","unstructured":"Fraser HS, Mucklow JC, Bulpitt CJ, Kahn C, Mould G, Dollery CT (1977) Environmental effects on antipyrine half-life in man. Clin Pharmacol Ther 22: 799?808","journal-title":"Clin Pharmacol Ther"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2125.1979.tb00928.x","volume":"7","author":"HS Fraser","year":"1977","unstructured":"Fraser HS, Mucklow JC, Bulpitt CJ, Kahn C, Mould G, Dollery CT (1977) Environmental factors affecting antipyrine metabolism in London factory and office workers. Br J Clin Pharmacol 7: 237?243","journal-title":"Br J Clin Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gut.14.7.569","volume":"14","author":"RA Branch","year":"1973","unstructured":"Branch RA, Hervert CM, Read AE (1973) Determinants of serum antipyrine half-lives in patients with liver disease. Gut 14: 569?573","journal-title":"Gut"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0016-5085(19)31662-2","volume":"75","author":"GC Farrell","year":"1978","unstructured":"Farrell GC, Cooksley WGE, Hart P, Powell LW (1978) Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. Gastroenterology 75: 580?588","journal-title":"Gastroenterology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.2.6028.147","volume":"2","author":"P Hart","year":"1976","unstructured":"Hart P, Farrell GC, Cooksley WGE, Powell LW (1976) Enhanced drug metabolism in cigarette smokers. Br Med J 2: 147?149","journal-title":"Br Med J"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00613931","volume":"24","author":"Y Horai","year":"1983","unstructured":"Horai Y, Ishizaki T, Sasaki T, Chiba K, Suganuma T, Echizen H, Ohnishi A (1983) Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study. Eur J Clin Pharmacol 24: 79?87","journal-title":"Eur J Clin Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00005792-195902000-00002","volume":"38","author":"WT Foulk","year":"1959","unstructured":"Foulk WT, Butt HR, Owen CA, Qhitcomb FF, Mason HL (1959) Constitutional hepatic dysfunction (Gilbert's disease): its natural history and related syndromes. Medicine 38: 25?46","journal-title":"Medicine"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003088-197904030-00004","volume":"4","author":"AF Macklon","year":"1979","unstructured":"Macklon AF, Savage RL, Rawlins MD (1979) Gilbert's syndrome and drug metabolism. Clin Pharmacokinet 4: 223?232","journal-title":"Clin Pharmacokinet"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/gut.17.8.581","volume":"17","author":"N Carulli","year":"1976","unstructured":"Carulli N, Ponz De Leon M, Mauro E, Manenti F, Ferrari A (1976) Alteration of drug metabolism in Gilbert's syndrome. Gut 17: 581?587","journal-title":"Gut"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00609984","volume":"13","author":"AP Douglas","year":"1978","unstructured":"Douglas AP, Savage RL, Rawlins MD (1978) Paracetamol (acetaminophen) kinetics in patients with Gilbert's syndrome. Eur J Clin Pharmacol 13: 209?212","journal-title":"Eur J Clin Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2362.1978.tb00856.x","volume":"8","author":"R Platzer","year":"1978","unstructured":"Platzer R, K\u00fcpfer A, Bircher J, Preisig R (1978) Polymorphic acetylation and aminopyrine demethylation in Gilbert's syndrome. Eur J Clin Invest 8: 219?223","journal-title":"Eur J Clin Invest"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0002-9343(70)80020-1","volume":"49","author":"PD Berk","year":"1970","unstructured":"Berk PD, Bloomer JR, Howe RB, Berlin NI (1970) Constitutional hepatic dysfunction (Gilbert's syndrome). A new definition based on kinetic studies with unconjugated radiobilirubin. Am J Med 49: 296?305","journal-title":"Am J Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0016-5085(76)80151-5","volume":"70","author":"JF Martin","year":"1976","unstructured":"Martin JF, Vierling JM, Wolkoff AW, Scharschmidt BF, Vergalla J, Waggoner JG, Berk PD (1976) Abnormal hepatic transport of indocyanine green in Gilbert's syndrome. Gastroenterology 70: 385?391","journal-title":"Gastroenterology"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/clpt.1982.169","volume":"32","author":"M D\u00f8ssing","year":"1982","unstructured":"D\u00f8ssing M (1982) Changes in hepatic microsomal enzyme function in workers exposed to mixtures of chemicals. Clin Pharmacol Ther 32: 340?346","journal-title":"Clin Pharmacol Ther"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1542\/peds.35.6.925","volume":"35","author":"M Michaelsson","year":"1965","unstructured":"Michaelsson M, Nosslin B, Sj\u00f6lin S (1965) Plasma bilirubin determination in the newborn infant. A methodological study with special reference to the influence of hemolysis. Pediatrics 35: 925?931","journal-title":"Pediatrics"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/cpt1976206643","volume":"20","author":"A Kappas","year":"1976","unstructured":"Kappas A, Anderson KE, Conney AH, Alvares AP (1976) Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin Pharmacol Ther 20: 643?653","journal-title":"Clin Pharmacol Ther"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.2042-7158.1973.tb10625.x","volume":"25","author":"LF Prescott","year":"1973","unstructured":"Prescott LF, Adjepon-Yamoah KK, Roberts E (1973) Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol 25: 205?207","journal-title":"J Pharm Pharmacol"},{"key":"CR21","first-page":"620","volume":"60","author":"K Chiba","year":"1982","unstructured":"Chiba K, Ishizaki T, Tabuchi T, Wagatsuma T, Nakazawa Y (1982) Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy. Obstet Gynecol 60: 620?626","journal-title":"Obstet Gynecol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01066061","volume":"6","author":"WJ Jusko","year":"1978","unstructured":"Jusko WJ (1978) Role of tobacco smoking in pharmacokinetics. J Pharmacokinet Biopharm 6: 7?39","journal-title":"J Pharmacokinet Biopharm"},{"key":"CR23","first-page":"17","volume":"116","author":"JR Powell","year":"1977","unstructured":"Powell JR, Thiercelin J-F, Vozeh S, Sansom L, Riegelman S (1977) The influence of cigarette smoking and sex on theophylline disposition. Am Rev Respir Dis 116: 17?23","journal-title":"Am Rev Respir Dis"},{"key":"CR24","first-page":"440","volume":"90","author":"GW Hepner","year":"1977","unstructured":"Hepner GW, Vesell ES, Lipton A, Harvey HA, Wilkinson GR, Schenker S (1977) Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination. J Lab Clin Med 90: 440?456","journal-title":"J Lab Clin Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/clpt.1982.154","volume":"32","author":"MWE Teunissen","year":"1982","unstructured":"Teunissen MWE, Srivastava AK, Breimer DD (1982) Influence of sex and oral contraceptive steroids on antipyrine metabolite formation. Clin Pharmacol Ther 32: 240?246","journal-title":"Clin Pharmacol Ther"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2125.1981.tb01305.x","volume":"12","author":"AR Boobis","year":"1981","unstructured":"Boobis AR, Brodie MJ, Kahn GC, Toverud E-L, Blair IA, Murray S, Davies DS (1981) Comparison of the in vivo rates of formation of the three main oxidative metabolites of antipyrine in man. Br J Clin Pharmacol 12: 771?777","journal-title":"Br J Clin Pharmacol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cpt197620181","volume":"20","author":"RA Branch","year":"1976","unstructured":"Branch RA, James JA, Read AE (1976) The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic liver disease. Clin Pharmacol Ther 20: 81?89","journal-title":"Clin Pharmacol Ther"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/bmj.1.6073.1384","volume":"1","author":"JAH Forrest","year":"1977","unstructured":"Forrest JAH, Finlayson NDC, Adjepon-Yamoah KK, Prescott LF (1977) Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease. Br Med J 1: 1384?1387","journal-title":"Br Med J"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2125.1979.tb00895.x","volume":"7","author":"AW Harman","year":"1979","unstructured":"Harman AW, Frewin DB, Priestly BG, Alexander CBJ (1979) Impairment of hepatic drug metabolism in alcoholics. Br J Clin Pharmacol 7: 45?48","journal-title":"Br J Clin Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00560360","volume":"7","author":"J Elfstr\u00f6m","year":"1974","unstructured":"Elfstr\u00f6m J, Lindgren S (1974) Disappearance of phenazone from plasma in patients with obstructive jaundice. Eur J Clin Pharmacol 7: 467?471","journal-title":"Eur J Clin Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/BF01316861","volume":"26","author":"J-P Miguet","year":"1981","unstructured":"Miguet J-P, Vuitton D, Deschamps J-P, Allemand H, Joanne C, Bechtel P, Carayon P (1981) Cholestasis and hepatic drug metabolism. Comparison of metabolic clearance rate of antipyrine in patients with intrahepatic or extrahepatic cholestasis. Dig Dis Sci 26: 718?722","journal-title":"Dig Dis Sci"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00542163\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T10:00:36Z","timestamp":1682848836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00542163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1984]]}},"alternative-id":["BF00542163"],"URL":"https:\/\/doi.org\/10.1007\/bf00542163","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984]]}}}